MedTrace Logo

Comparison of Long vs. Short Acting Anesthesia for Improving Pain Management After Breast Biopsy

NCT02085239 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2018-09-12

No results posted yet for this study

Summary

This study will evaluate the potential role of a long acting anesthetic (ropivacaine) in providing an extended period of pain relief for patients undergoing ultrasound guided core biopsy of the breast.

Conditions

  • Pain Management After Breast Biopsy

Interventions

DRUG

Lidocaine Ropivacaine

* 8-10 ml of Lidocaine given by subcutaneous injection * 8-10 ml of Ropivacaine given by subcutaneous injection

DRUG

Lidocaine alone

Sponsors & Collaborators

  • TriHealth Inc.

    lead OTHER

Principal Investigators

  • Dean Shanley, MD · TriHealth Inc.

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02085239 on ClinicalTrials.gov